Pamicell, Foreign Investors Net Sell 7,000 Shares... Stock Price Down 0.57%

Pamissel has ranked among the top searched stocks for 15 days in the past month.

As of 2:30 PM on the 2nd, Pamissel is trading at 17,700 KRW, up 0.57% from the previous day. This marks a 13.46% increase compared to October 19. Pamissel is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners have a tentative net sale of 7,000 shares of Pamissel, while institutions have a net purchase of 8,000 shares. Over the past five days, individual investors have net sold 21,655 shares, foreigners have net bought 17,960 shares, and institutions have net sold 22,427 shares.

On October 30, Pamissel was a market topic due to the news of 'Moderna's COVID-19 vaccine WHO supply negotiations' showing strong performance.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.